Levalbuterol (hydrochloride)

Levalbuterol ((R) -Albuterol) hydrochloride is a short-acting β2-adrenergic receptor agonist and the active (R) -enantiomer of Salbutamol. Levalbuterol hydrochloride is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD[1].

Product Specifications

CAS Number

[50293-90-8]

Product Name Alternative

(R) -Albuterol (hydrochloride) ; (R) -Salbutamol (hydrochloride) ; Levosalbutamol (hydrochloride)

UNSPSC

12352005

Hazard Statement

H302, H315, H318, H335

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/levalbuterol-hydrochloride.html

Purity

99.93

Solubility

H2O : 100 mg/mL (ultrasonic)

Smiles

CC(C)(NC[C@@H](C1=CC=C(C(CO)=C1)O)O)C.[H]Cl

Molecular Formula

C13H22ClNO3

Molecular Weight

275.78

Precautions

H302, H315, H318, H335

References & Citations

[1]Randall MJ, et, al. Anti-inflammatory effects of levalbuterol-induced 11β-hydroxysteroid dehydrogenase type 1 activity in airway epithelial cells. Front Endocrinol (Lausanne) . 2015 Jan 12;5:236.|[2]Ferrada MA, et, al. (R) -albuterol decreases immune responses: role of activated T cells. Respir Res. 2008 Jan 14;9 (1) :3.